These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31783084)

  • 1. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
    Caputo D; Caracciolo G
    Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection.
    Caputo D; Quagliarini E; Pozzi D; Caracciolo G
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
    Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study.
    Caputo D; Cartillone M; Cascone C; Pozzi D; Digiacomo L; Palchetti S; Caracciolo G; Coppola R
    Pancreatology; 2018 Sep; 18(6):661-665. PubMed ID: 29914752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-metabolite panel for early-stage pancreatic cancer.
    Burki TK
    Lancet Oncol; 2018 Oct; 19(10):e512. PubMed ID: 30146244
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in pancreatic cancer research: moving towards early detection.
    He XY; Yuan YZ
    World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of lifestyle, metabolic risk factors, and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma.
    Pang Y; Holmes MV; Chen Z; Kartsonaki C
    J Gastroenterol Hepatol; 2019 Feb; 34(2):330-345. PubMed ID: 30550622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer.
    Kunovsky L; Tesarikova P; Kala Z; Kroupa R; Kysela P; Dolina J; Trna J
    Can J Gastroenterol Hepatol; 2018; 2018():5389820. PubMed ID: 30186820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Fit-For-Purpose Multi-Marker Panel for Early Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Kim H; Huh S; Park J; Han Y; Ahn KG; Noh Y; Lee SJ; Chu H; Kim SS; Jung HS; Yun WG; Cho YJ; Kwon W; Jang JY; Kang UB
    Mol Cell Proteomics; 2024 Sep; 23(9):100824. PubMed ID: 39097268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
    Bardol T; Dujon AM; Taly V; Dunyach-Remy C; Lavigne JP; Costa-Silva B; Kurma K; Eslami-S Z; Cayrefourcq L; Canivet C; Muscari F; Bournet B; Alix-Panabières C
    BMC Cancer; 2024 Jun; 24(1):709. PubMed ID: 38853244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.
    Yako YY; Kruger D; Smith M; Brand M
    PLoS One; 2016; 11(5):e0154016. PubMed ID: 27170998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting the personalized biomolecular corona of graphene oxide nanoflakes into a high-throughput diagnostic test for early cancer detection.
    Papi M; Palmieri V; Digiacomo L; Giulimondi F; Palchetti S; Ciasca G; Perini G; Caputo D; Cartillone MC; Cascone C; Coppola R; Capriotti AL; Laganà A; Pozzi D; Caracciolo G
    Nanoscale; 2019 Aug; 11(32):15339-15346. PubMed ID: 31386742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer - a comprehensive review.
    Reese KL; Pantel K; Smit DJ
    J Exp Clin Cancer Res; 2024 Sep; 43(1):250. PubMed ID: 39218911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles.
    Digiacomo L; Caputo D; Coppola R; Cascone C; Giulimondi F; Palchetti S; Pozzi D; Caracciolo G
    Biointerphases; 2021 Feb; 16(1):011010. PubMed ID: 33706529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
    Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.
    Udgata S; Takenaka N; Bamlet WR; Oberg AL; Yee SS; Carpenter EL; Herman D; Kim J; Petersen GM; Zaret KS
    Cancer Prev Res (Phila); 2021 Feb; 14(2):223-232. PubMed ID: 33067248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.